perm kit (Multi Sciences (Lianke) Biotech Co Ltd)
Multi Sciences (Lianke) Biotech Co Ltd is a verified supplier 
Multi Sciences (Lianke) Biotech Co Ltd manufactures this product 
95
Structured Review
Multi Sciences (Lianke) Biotech Co Ltd
perm kit
Perm Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 146 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/perm+kit/Fix+%26+Perm+Kit/10__34133_slash_bmr__0370-141-21-23
Average 95 stars, based on 146 article reviews
Perm Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 146 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/perm+kit/Fix+%26+Perm+Kit/10__34133_slash_bmr__0370-141-21-23
Average 95 stars, based on 146 article reviews
perm kit - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Flow Cytometry:Article Title: Co-delivery nanoparticle targeting CAF for simultaneous activating T cell plus NKT cell attack in solid tumor. Article Snippet: Data represent mean ± SD (n = 12). purchased from Affymetrix eBioscience Co., Ltd. (San Diego, USA). .. The antibodies and kit used in flow cytometry are listed as follows: anti-CD3 antibody (1:200, Elabscience, E-AB-F1013S, Elab Fluor® Red 780), anti-a-GC/CD1d tetramer antibody (1:300, ProImmune, E001-2A-G, PE), Fix & Article Title: Large-scale screening of HBV epitopes restricted by multiple prevalent HLA-B/C allotypes and routine detection of HBV-specific T cells in CHB patients Article Snippet: .. After washing, the cells were fixed and permeabilized using the Fix & other:Article Title: Routine detection of reactive Cyfra21-1-specific CD8 + T cells and its predictive value for responsiveness to PD-1/PD-L1 inhibitor therapy in NSCLC patients. Article Snippet: Immune checkpoint inhibitors are widely used in non-small cell lung cancer (NSCLC), but with limited overall response rates.. Indicators predicting immunotherapy response are hard to routinely detect due to their invasiveness.. This study systematically screened for CD8 T-cell epitopes in Cytokeratin Fragment Antigen 21-1 (Cyfra21-1), a valuable NSCLC tumor marker, through a combination of in silico prediction, ex vivo co-cultures of peptides with patient-derived peripheral blood mononuclear cells (PBMCs), peptide competition binding assays, and peptide immunization in humanized mice. Staining:Article Title: Large-scale screening of HBV epitopes restricted by multiple prevalent HLA-B/C allotypes and routine detection of HBV-specific T cells in CHB patients Article Snippet: .. After washing, the cells were fixed and permeabilized using the Fix & Article Title: Tryptophan-enriched Lactobacillus rhamnosus GG-derived Nanovesicles Promote Alveolar Bone Regeneration Through Macrophage Fatty Acid Oxidation Article Snippet: To ensure proper staining of CD206, which can be detected as an intracellular protein, permeabilization step was performed using Fix & Perm Kit (Liankebio, China). .. To ensure proper staining of CD206, which can be detected as an intracellular protein, permeabilization step was performed using Fix & Article Title: CTLA-4 nanovesicles disrupt dendritic cell-driven CD8 T cell priming for myocardial infarction therapy. Article Snippet: Myocardial infarction (MI) remains a formidable global health challenge, as current therapies are hindered by excessive inflammation that exacerbates cardiac dysfunction and accelerates disease progression.. Cytotoxic Tlymphocyte antigen 4 (CTLA-4) and CD28 are T-lymphocyte receptors with opposing roles in T-cell activation: CD28 binding to CD80/CD86 ligands on dendritic cells (DCs) mediates co-stimulation, whereas CTLA-4 engagement delivers inhibitory signals.. In our present study, mannosylated cytotoxic T-lymphocyte antigen 4 (CTLA-4)-presenting small extracellular vesicles (CM@sEVs) were engineered for targeted MI therapy. Article Title: Effects of Silymarin Combined with Herbal Medicine on Th17/Treg Cell Imbalance and Inflammatory Response in Patients with Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Article Snippet: CD4+ IL-17A+ Th17 cells were incubated with FITC-conjugated antihuman CD4 (eBioscience) following a 5-hour stimulation with a PMA/ionomycin/BFA/monensin mixture (MULTISCIENCES; Hangzhou, Zhejiang province, China). .. After permeabilizing the cell membrane using a Fix & Antibody Labeling:Article Title: CTLA-4 nanovesicles disrupt dendritic cell-driven CD8 T cell priming for myocardial infarction therapy. Article Snippet: Myocardial infarction (MI) remains a formidable global health challenge, as current therapies are hindered by excessive inflammation that exacerbates cardiac dysfunction and accelerates disease progression.. Cytotoxic Tlymphocyte antigen 4 (CTLA-4) and CD28 are T-lymphocyte receptors with opposing roles in T-cell activation: CD28 binding to CD80/CD86 ligands on dendritic cells (DCs) mediates co-stimulation, whereas CTLA-4 engagement delivers inhibitory signals.. In our present study, mannosylated cytotoxic T-lymphocyte antigen 4 (CTLA-4)-presenting small extracellular vesicles (CM@sEVs) were engineered for targeted MI therapy. Membrane:Article Title: Effects of Silymarin Combined with Herbal Medicine on Th17/Treg Cell Imbalance and Inflammatory Response in Patients with Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Article Snippet: CD4+ IL-17A+ Th17 cells were incubated with FITC-conjugated antihuman CD4 (eBioscience) following a 5-hour stimulation with a PMA/ionomycin/BFA/monensin mixture (MULTISCIENCES; Hangzhou, Zhejiang province, China). .. After permeabilizing the cell membrane using a Fix & |